November 28, 2023

New contamination-detection test to improve T-cell therapy

Method to improve sterility assurance in biopharmaceutical manufacturing will lead to better patient outcomes.

A novel method that can identify contaminants in T cell cultures within 24 hours has been developed by researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE) and Massachusetts Institute of Technology (MIT).

https://www.drugtargetreview.com/news/112861/new-contamination-detection-test-to-improve-t-cell-therapy/

https://journals.asm.org/doi/epub/10.1128/spectrum.01350-23